Reference |
All identification details of the paper |
Year |
Year of publication |
Country |
Country in which the study was carried out |
Study Design |
Type of study conducted |
Patient (P) |
Population receiving both specific and nonspecific Potentially Inappropriate Prescribing (PIPs) |
Intervention (I) |
Any type of intervention aimed at health professionals (i.e., physicians, clinicians, pharmacists, nurses), structures (i.e., nursing homes, hospitals, pharmacies), patients, or any monitoring activities of potentially inappropriate prescriptions and costs incurred use any explicit criteria for identifying inappropriateness (such as Beers Criteria, PRISCUS list, STOPP/START criteria) |
Comparator (C) |
No intervention or any other intervention and no monitoring activities |
Outcomes (O) |
The postintervention outcome in terms of costs variation and intervention effectiveness; Avoidable costs related to inappropriate prescriptions |
Cost types |
The perspective of analysis (NHS, society, government, patient) and associated costs (direct healthcare costs, direct non healthcare costs, indirect costs, intangible costs) |